blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3439647

EP3439647 - COMPOSITION FOR USE IN REDUCING OR PREVENTING GLOBAL DEVELOPMENTAL DELAY IN CHILDREN [Right-click to bookmark this link]
Former [2019/07]METHOD FOR REDUCING OR PREVENTING GLOBAL DEVELOPMENTAL DELAY IN CHILDREN
[2022/41]
StatusThe patent has been granted
Status updated on  17.02.2023
Database last updated on 14.09.2024
FormerGrant of patent is intended
Status updated on  26.09.2022
FormerExamination is in progress
Status updated on  09.03.2020
FormerRequest for examination was made
Status updated on  11.01.2019
FormerThe international publication has been made
Status updated on  13.10.2017
Most recent event   Tooltip31.07.2024New entry: Date of oral proceedings 
Applicant(s)For all designated states
N.V. Nutricia
Eerste Stationsstraat 186
2712 HM Zoetermeer / NL
[2019/07]
Inventor(s)01 / VAN ELBURG, Ruurd
Uppsalalaan 12
3584 CT Utrecht / NL
02 / VOS, Arjen Paul
Uppsalalaan 12
3584 CT Utrecht / NL
03 / COUNOTTE, Danielle Stefanie
Uppsalalaan 12
3584 CT Utrecht / NL
04 / SMORENBURG, Ana Renée Pascale
Uppsalalaan 12
3584 CT Utrecht / NL
 [2019/07]
Representative(s)Nederlandsch Octrooibureau
P.O. Box 29720
2502 LS The Hague / NL
[2019/07]
Application number, filing date16730030.004.04.2016
[2019/07]
WO2016NL50232
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017176109
Date:12.10.2017
Language:EN
[2017/41]
Type: A1 Application with search report 
No.:EP3439647
Date:13.02.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 12.10.2017 takes the place of the publication of the European patent application.
[2019/07]
Type: B1 Patent specification 
No.:EP3439647
Date:22.03.2023
Language:EN
[2023/12]
Search report(s)International search report - published on:EP12.10.2017
ClassificationIPC:A61K31/14, A61K31/7068, A61K31/7072, A61K31/714, A61K33/18, A61K33/30, A61P25/00, A61K31/202
[2022/41]
CPC:
A61K31/202 (EP,US); A61K31/14 (EP,US); A61K31/7068 (EP,US);
A61K31/7072 (EP,US); A61K31/714 (EP,US); A61K33/18 (EP,US);
A61K33/30 (EP,US); A61P25/00 (EP,US) (-)
C-Set:
A61K31/14, A61K2300/00 (EP,US);
A61K31/202, A61K2300/00 (US,EP);
A61K31/7068, A61K2300/00 (US,EP);
A61K31/7072, A61K2300/00 (US,EP)
Former IPC [2019/07]A61K31/14, A61K31/202, A61K31/7068, A61K31/7072, A61P25/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/07]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:ZUBEREITUNG ZUR VERMINDERUNG ODER VERHINDERUNG VON GLOBALER ENTWICKLUNGSVERZÖGERUNG BEI KINDERN[2022/41]
English:COMPOSITION FOR USE IN REDUCING OR PREVENTING GLOBAL DEVELOPMENTAL DELAY IN CHILDREN[2022/41]
French:COMPOSITION POUR LA RÉDUCTION OU LA PRÉVENTION D'UN RETARD DE DÉVELOPPEMENT GLOBAL CHEZ DES ENFANTS[2022/41]
Former [2019/07]VERFAHREN ZUR VERMINDERUNG ODER VERHINDERUNG VON GLOBALER ENTWICKLUNGSVERZÖGERUNG BEI KINDERN
Former [2019/07]METHOD FOR REDUCING OR PREVENTING GLOBAL DEVELOPMENTAL DELAY IN CHILDREN
Former [2019/07]PROCÉDÉ DE RÉDUCTION OU DE PRÉVENTION D'UN RETARD DE DÉVELOPPEMENT GLOBAL CHEZ DES ENFANTS
Entry into regional phase04.10.2018National basic fee paid 
04.10.2018Designation fee(s) paid 
04.10.2018Examination fee paid 
Examination procedure04.10.2018Examination requested  [2019/07]
04.10.2018Date on which the examining division has become responsible
13.05.2019Amendment by applicant (claims and/or description)
12.03.2020Despatch of a communication from the examining division (Time limit: M04)
21.07.2020Reply to a communication from the examining division
03.05.2021Cancellation of oral proceeding that was planned for 24.09.2021
11.05.2021Despatch of a communication from the examining division (Time limit: M02)
13.07.2021Reply to a communication from the examining division
24.09.2021Date of oral proceedings (cancelled)
27.09.2022Communication of intention to grant the patent
25.01.2023Fee for grant paid
25.01.2023Fee for publishing/printing paid
25.01.2023Receipt of the translation of the claim(s)
Opposition(s)Opponent(s)01  21.12.2023  02.01.2024  ADMISSIBLE
Société des Produits Nestlé S.A.
Entre-deux-Villes
1800 Vevey / CH
Opponent's representative
D Young & Co LLP
3 Noble Street
London EC2V 7BQ / GB
 [N/P]
Former [2024/06]
Opponent(s)01  21.12.2023  02.01.2024  ADMISSIBLE
Société des Produits Nestlé S.A.
Entre-deux-Villes
1800 Vevey / CH
Opponent's representative
D Young & Co LLP
120 Holborn
London EC1N 2DY / GB
Former [2024/05]
Opponent(s)01  21.12.2023   
Société des Produits Nestlé S.A.
Entre-deux-Villes
1800 Vevey / CH
Opponent's representative
D Young & Co LLP
120 Holborn
London EC1N 2DY / GB
12.01.2024Invitation to proprietor to file observations on the notice of opposition
25.04.2024Reply of patent proprietor to notice(s) of opposition
18.02.2025Date of oral proceedings
Fees paidRenewal fee
04.10.2018Renewal fee patent year 03
27.03.2019Renewal fee patent year 04
25.03.2020Renewal fee patent year 05
30.03.2021Renewal fee patent year 06
29.03.2022Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT22.03.2023
CZ22.03.2023
DK22.03.2023
EE22.03.2023
FI22.03.2023
HR22.03.2023
LT22.03.2023
LV22.03.2023
MC22.03.2023
RO22.03.2023
RS22.03.2023
SE22.03.2023
SI22.03.2023
SK22.03.2023
SM22.03.2023
LU04.04.2023
BE30.04.2023
NO22.06.2023
GR23.06.2023
IS22.07.2023
PT24.07.2023
[2024/10]
Former [2024/08]AT22.03.2023
EE22.03.2023
FI22.03.2023
HR22.03.2023
LT22.03.2023
LV22.03.2023
MC22.03.2023
RO22.03.2023
RS22.03.2023
SE22.03.2023
SK22.03.2023
SM22.03.2023
LU04.04.2023
NO22.06.2023
GR23.06.2023
IS22.07.2023
PT24.07.2023
Former [2024/04]AT22.03.2023
EE22.03.2023
FI22.03.2023
HR22.03.2023
LT22.03.2023
LV22.03.2023
RO22.03.2023
RS22.03.2023
SE22.03.2023
SK22.03.2023
SM22.03.2023
LU04.04.2023
NO22.06.2023
GR23.06.2023
IS22.07.2023
PT24.07.2023
Former [2023/50]AT22.03.2023
EE22.03.2023
FI22.03.2023
HR22.03.2023
LT22.03.2023
LV22.03.2023
RO22.03.2023
RS22.03.2023
SE22.03.2023
SK22.03.2023
SM22.03.2023
NO22.06.2023
GR23.06.2023
IS22.07.2023
PT24.07.2023
Former [2023/49]AT22.03.2023
EE22.03.2023
FI22.03.2023
HR22.03.2023
LT22.03.2023
LV22.03.2023
RO22.03.2023
RS22.03.2023
SE22.03.2023
SM22.03.2023
NO22.06.2023
GR23.06.2023
PT24.07.2023
Former [2023/48]AT22.03.2023
EE22.03.2023
FI22.03.2023
HR22.03.2023
LT22.03.2023
LV22.03.2023
RS22.03.2023
SE22.03.2023
SM22.03.2023
NO22.06.2023
GR23.06.2023
PT24.07.2023
Former [2023/46]FI22.03.2023
HR22.03.2023
LT22.03.2023
LV22.03.2023
RS22.03.2023
SE22.03.2023
SM22.03.2023
NO22.06.2023
GR23.06.2023
PT24.07.2023
Former [2023/37]FI22.03.2023
HR22.03.2023
LT22.03.2023
LV22.03.2023
RS22.03.2023
SE22.03.2023
NO22.06.2023
GR23.06.2023
Former [2023/36]FI22.03.2023
HR22.03.2023
LT22.03.2023
LV22.03.2023
RS22.03.2023
SE22.03.2023
NO22.06.2023
Former [2023/35]HR22.03.2023
LT22.03.2023
RS22.03.2023
NO22.06.2023
Former [2023/34]LT22.03.2023
RS22.03.2023
Former [2023/33]LT22.03.2023
Cited inInternational search[X]WO0178530  (ABBOTT LAB [US]) [X] 1-25 * Neurological development; page 9 * * Experimental Design; page 26 - page 27 * * page 47, paragraph 1 * * page 48; table 8 * * claims 1-22 *;
 [X]WO2012125020  (NUTRICIA NV [NL], et al) [X] 1-25 * page 21 - page 23; examples 2,3 *;
 [T]  - Anonymous, "Product Information: Similac NeoSure Similac NeoSure Infant Formula with Iron", (20160719), pages 1 - 6, URL: http://static.abbottnutrition.com/cms-prod/abbottnutrition.com/img/Similac-NeoSure.pdf, (20161025), XP055313841 [T] 1-25 * page 2 * * page 4 *
by applicantWO2012125034
    - BOS, A, DEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, (2013), vol. 55, pages 973 - 979
OppositionWO0178530
 US2002028787
 US2005176676
 US2005203053
 WO2007073177
 WO2012125020
 WO2014109862
    - Morag J Andrew;Jeremy R Parr;Chris Montague-Johnson;Oliver Braddick;Karen Laler;Nicola Williams;Bonny Baker;Peter B Sullivan, "Optimising nutrition to improve growth and reduce neurodisabilities in neonates at risk of neurological impairment, and children with suspected or confirmed cerebral palsy", BMC PEDIATRICS, BIOMED CENTRAL, LONDON, GB, GB , (20150317), vol. 15, no. 1, doi:10.1186/s12887-015-0339-2, ISSN 1471-2431, page 22, XP021217171

DOI:   http://dx.doi.org/10.1186/s12887-015-0339-2
    - Gil A; Ramirez M; Gil M, "Role of long-chain polyunsaturated fatty acids in infant nutrition", European Journal of Clinical Nutrition, Nature Publishing Group, GB, GB , (20030828), vol. 57, no. Suppl 1, doi:10.1038/sj.ejcn.1601810, ISSN 0954-3007, pages S31 - S34, XP037762848

DOI:   http://dx.doi.org/10.1038/sj.ejcn.1601810
    - COSGROVE M, "Perinatal and infant nutrition. Nucleotides.", Nutrition, Elsevier, AMSTERDAM, NL, AMSTERDAM, NL , (19981001), vol. 14, no. 10, ISSN 0899-9007, pages 748 - 751, XP002561642
    - Anonymous, "Similac® NeoSure®", Product Data Sheet, (20230422), pages 1 - 4, XP093150296
    - Clandinin, M.T. Van Aerde, J.E. Merkel, K.L. Harris, C.L. Springer, M.A. Hansen, J.W. Diersen-Schade, D.A., "Growth and development of preterm infants fed infant formulas containing docosahexaenoic acid and arachidonic acid", JOURNAL OF PEDIATRICS., MOSBY-YEAR BOOK, ST. LOUIS, MO, US, US , (20050401), vol. 146, no. 4, doi:10.1016/j.jpeds.2004.11.030, ISSN 0022-3476, pages 461 - 468, XP004841103

DOI:   http://dx.doi.org/10.1016/j.jpeds.2004.11.030
    - Eileen E Birch; Sharon Garfield; Dennis R Hoffman; Ricardo Uauy; David G Birch, "A randomized controlled trial of early dietary supply of long‐chain polyunsaturated fatty acids and mental development in term infants", Developmental Medicine & Child Neurology, HEINEMANN WILLIAM MEDICAL BOOKS, LONDON, GB, GB , (20070213), vol. 42, no. 3, doi:10.1111/j.1469-8749.2000.tb00066.x, ISSN 0012-1622, pages 174 - 181, XP071194698

DOI:   http://dx.doi.org/10.1111/j.1469-8749.2000.tb00066.x
    - Makrides Maria, Gibson Robert A, Mcphee Andrew J, Collins Carmel T, Davis Peter G, Doyle Lex W, Simmer Karen, Colditz Paul B, Morris Scott, Smithers Lisa G, Willson Kristyn, Ryan Philip, "Neurodevelopmental Outcomes of Preterm Infants Fed High-Dose Docosahexaenoic Acid: A Randomized Controlled Trial", JAMA, American Medical Association, (20090114), vol. 301, no. 2, doi:10.1001/jama.2008.945, ISSN 0098-7484, pages 175 - 182, XP093150298

DOI:   http://dx.doi.org/10.1001/jama.2008.945
    - Wurtman, R.J. Ulus, I.H. Cansev, M. Watkins, C.J. Wang, L. Marzloff, G., "Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally", Brain Research, ELSEVIER, Amsterdam, NL, NL , (20060509), vol. 1088, no. 1, doi:10.1016/j.brainres.2006.03.019, ISSN 0006-8993, pages 83 - 92, XP005446770

DOI:   http://dx.doi.org/10.1016/j.brainres.2006.03.019
    - Cansev Mehmet, Marzloff George, Sakamoto Toshimasa, Ulus Ismail H., Wurtman Richard J., "Giving Uridine and/or Docosahexaenoic Acid Orally to Rat Dams during Gestation and Nursing Increases Synaptic Elements in Brains of Weanling Pups", Developmental Neuroscience, (20090115), vol. 31, doi:10.1159/000193394, pages 181 - 192, XP093150302

DOI:   http://dx.doi.org/10.1159/000193394
    - Sakamoto, T. Cansev, M. Wurtman, R.J., "Oral supplementation with docosahexaenoic acid and uridine-5'-monophosphate increases dendritic spine density in adult gerbil hippocampus", Brain Research, ELSEVIER, Amsterdam, NL, NL , (20071113), vol. 1182, doi:10.1016/j.brainres.2007.08.089, ISSN 0006-8993, pages 50 - 59, XP022343045

DOI:   http://dx.doi.org/10.1016/j.brainres.2007.08.089
    - S. Holguin, J. Martinez, C. Chow, R. Wurtman, "Dietary uridine enhances the improvement in learning and memory produced by administering DHA to gerbils", The FASEB Journal, The Federation, (20081101), vol. 22, no. 11, doi:10.1096/fj.08-112425, ISSN 08926638, pages 3938 - 3946, XP055006757

DOI:   http://dx.doi.org/10.1096/fj.08-112425
    - Albers Craig A., Grieve Adam J., "Test reviews", Journal of Psychoeducational Assessment, (20070601), vol. 25, no. 2, pages 180 - 198, XP093150304
    - Bélanger Stacey A, Caron Joannie, "Evaluation of the child with global developmental delay and intellectual disability", Paediatrics & child health : the journal of the Canadian Paediatric Society ; journal de la Société Canadienne de Pédiatrie, Pulsus Group, Oakville, Ont., Canada, Oakville, Ont., Canada , (20180816), vol. 23, no. 6, doi:10.1093/pch/pxy093, ISSN 1205-7088, pages 403 - 410, XP093150309

DOI:   http://dx.doi.org/10.1093/pch/pxy093
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.